PRIMENE 10%-LIQ IV 1.1 G / 100 ML — DIN 02161192
L-LYSINE : 1.1 G / 100 ML L-ORNITHINE : 249 MG / 100 ML L-CYSTEINE HYDROCHLORIDE : 246 MG / 100 ML GLYCINE : 400 MG / 100 ML METHIONINE : 240 MG / 100 ML L-TYROSINE : 45 MG / 100 ML TAURINE : 60 MG / 100 ML L-VALINE : 760 MG / 100 ML L-ALANINE : 800 MG / 100 ML L-PROLINE : 300 MG / 100 ML L-ISOLEUCINE : 670 MG / 100 ML SERINE : 400 MG / 100 ML L-THREONINE : 370 MG / 100 ML HISTIDINE : 380 MG / 100 ML L-ASPARTIC ACID : 600 MG / 100 ML GLUTAMIC ACID : 1 G / 100 ML L-LEUCINE : 1 G / 100 ML L-ARGININE : 840 MG / 100 ML TRYPTOPHAN : 200 MG / 100 ML L-PHENYLALANINE : 420 MG / 100 ML · CLINTEC NUTRITION COMPANY · LIQUID · wholesale supply in Canada
Health Canada status: CANCELLED POST MARKET
What is PRIMENE 10%-LIQ IV?
PRIMENE 10%-LIQ IV 1.1 G / 100 ML contains L-LYSINE : 1.1 G / 100 ML L-ORNITHINE : 249 MG / 100 ML L-CYSTEINE HYDROCHLORIDE : 246 MG / 100 ML GLYCINE : 400 MG / 100 ML METHIONINE : 240 MG / 100 ML L-TYROSINE : 45 MG / 100 ML TAURINE : 60 MG / 100 ML L-VALINE : 760 MG / 100 ML L-ALANINE : 800 MG / 100 ML L-PROLINE : 300 MG / 100 ML L-ISOLEUCINE : 670 MG / 100 ML SERINE : 400 MG / 100 ML L-THREONINE : 370 MG / 100 ML HISTIDINE : 380 MG / 100 ML L-ASPARTIC ACID : 600 MG / 100 ML GLUTAMIC ACID : 1 G / 100 ML L-LEUCINE : 1 G / 100 ML L-ARGININE : 840 MG / 100 ML TRYPTOPHAN : 200 MG / 100 ML L-PHENYLALANINE : 420 MG / 100 ML. It is listed in the Health Canada Drug Product Database under DIN 02161192, held by CLINTEC NUTRITION COMPANY, supplied as LIQUID for INTRAVENOUS administration. Health Canada currently lists it as cancelled post market, status dated 13-Aug-1998. This Drug Identification Number is no longer authorized for sale in Canada, so Nexara does not supply it. The record is kept here because buyers still meet the number on old formularies, purchase orders and tender documents; Nexara can help identify an authorized alternative.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 1.1 G / 100 ML |
|---|---|
| Dosage form | LIQUID |
| Route | INTRAVENOUS |
Pack detail is kept as a regulatory record. This DIN is no longer authorized for sale in Canada, so Nexara does not quote this pack.
Substance and classification
| Active substance | Amino Acids, Incl Combinations With Polypeptides |
|---|---|
| ATC code | V06DD |
| AHFS class | 88:28.01* ; See footnote |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02161192 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2161192 |
| Brand name | PRIMENE 10%-LIQ IV |
| Generic / active ingredient | L-LYSINE : 1.1 G / 100 ML L-ORNITHINE : 249 MG / 100 ML L-CYSTEINE HYDROCHLORIDE : 246 MG / 100 ML GLYCINE : 400 MG / 100 ML METHIONINE : 240 MG / 100 ML L-TYROSINE : 45 MG / 100 ML TAURINE : 60 MG / 100 ML L-VALINE : 760 MG / 100 ML L-ALANINE : 800 MG / 100 ML L-PROLINE : 300 MG / 100 ML L-ISOLEUCINE : 670 MG / 100 ML SERINE : 400 MG / 100 ML L-THREONINE : 370 MG / 100 ML HISTIDINE : 380 MG / 100 ML L-ASPARTIC ACID : 600 MG / 100 ML GLUTAMIC ACID : 1 G / 100 ML L-LEUCINE : 1 G / 100 ML L-ARGININE : 840 MG / 100 ML TRYPTOPHAN : 200 MG / 100 ML L-PHENYLALANINE : 420 MG / 100 ML |
| Market authorization holder | CLINTEC NUTRITION COMPANY |
| Health Canada schedule | Ethical |
| ATC code | V06DD |
| ATC anatomical main group | V — Various |
| ATC therapeutic subgroup | V06DD |
| Current status | CANCELLED POST MARKET |
| Status date | 13-Aug-1998 |
| Original market date | 1995-12-31 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
2 · Same class — other molecules in ATC V06DD
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Amino Acids, Incl Combinations With Polypeptides | PRIMENE 10%-LIQ IV | 1 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC V06D
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| V06D | Other Nutrients | 1 | 0 |
| V06DB | Fat/Carbohydrates/Proteins/Minerals/Vitamins, Comb | 2 | 0 |
| V06DC | Glucose | 1 | 0 |
| V06DE | Amino Acids/Carbohydrates/Minerals/Vitamins, Comb | 1 | 0 |
| V06DX | Other Combinations Of Nutrients | 15 | 0 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.